AMLX
Price
$8.01
Change
-$0.40 (-4.76%)
Updated
Aug 15, 04:59 PM (EDT)
Capitalization
749.9M
83 days until earnings call
ANVS
Price
$2.74
Change
+$0.02 (+0.74%)
Updated
Aug 15, 04:59 PM (EDT)
Capitalization
53M
82 days until earnings call
Interact to see
Advertisement

AMLX vs ANVS

Header iconAMLX vs ANVS Comparison
Open Charts AMLX vs ANVSBanner chart's image
Amylyx Pharmaceuticals
Price$8.01
Change-$0.40 (-4.76%)
Volume$19.9K
Capitalization749.9M
Annovis Bio
Price$2.74
Change+$0.02 (+0.74%)
Volume$13.15K
Capitalization53M
AMLX vs ANVS Comparison Chart in %
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. ANVS commentary
Aug 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Hold and ANVS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 15, 2025
Stock price -- (AMLX: $8.41 vs. ANVS: $2.72)
Brand notoriety: AMLX and ANVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 34% vs. ANVS: 40%
Market capitalization -- AMLX: $749.9M vs. ANVS: $53M
AMLX [@Biotechnology] is valued at $749.9M. ANVS’s [@Biotechnology] market capitalization is $53M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.07B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileANVS’s FA Score has 1 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • ANVS’s FA Score: 1 green, 4 red.
According to our system of comparison, AMLX is a better buy in the long-term than ANVS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 4 TA indicator(s) are bullish while ANVS’s TA Score has 3 bullish TA indicator(s).

  • AMLX’s TA Score: 4 bullish, 4 bearish.
  • ANVS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AMLX is a better buy in the short-term than ANVS.

Price Growth

AMLX (@Biotechnology) experienced а +7.27% price change this week, while ANVS (@Biotechnology) price change was +4.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.95%. For the same industry, the average monthly price growth was +21.44%, and the average quarterly price growth was +21.23%.

Reported Earning Dates

AMLX is expected to report earnings on Nov 06, 2025.

ANVS is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+5.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($750M) has a higher market cap than ANVS($53M). AMLX YTD gains are higher at: 122.487 vs. ANVS (-45.924). ANVS has higher annual earnings (EBITDA): -25.17M vs. AMLX (-206.81M). AMLX has more cash in the bank: 204M vs. ANVS (22.2M). ANVS has higher revenues than AMLX: ANVS (0) vs AMLX (-1.27M).
AMLXANVSAMLX / ANVS
Capitalization750M53M1,415%
EBITDA-206.81M-25.17M822%
Gain YTD122.487-45.924-267%
P/E Ratio2.69N/A-
Revenue-1.27M0-
Total Cash204M22.2M919%
Total Debt1.38MN/A-
TECHNICAL ANALYSIS
Technical Analysis
AMLXANVS
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 11 days ago
83%
Declines
ODDS (%)
Bearish Trend 8 days ago
81%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
71%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SOIEF30.51N/A
N/A
Stolt-Nielsen Ltd
TRYIF6.63N/A
N/A
Toray Industries Inc.
SMOPF1.85N/A
N/A
SMARTOPTICS GROUP AS
SICLQ9.25N/A
N/A
Silvergate Capital Corporation
SCIA4.00-0.25
-5.88%
SCI Engineered Materials, Inc.

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been closely correlated with XOMAO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AMLX jumps, then XOMAO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
+1.33%
XOMAO - AMLX
68%
Closely correlated
-0.39%
XOMAP - AMLX
51%
Loosely correlated
+0.27%
RGNX - AMLX
45%
Loosely correlated
+1.46%
LRMR - AMLX
43%
Loosely correlated
+14.52%
OCUL - AMLX
43%
Loosely correlated
+1.20%
More

ANVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANVS has been loosely correlated with ADXN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ANVS jumps, then ADXN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANVS
1D Price
Change %
ANVS100%
+0.74%
ADXN - ANVS
43%
Loosely correlated
-0.24%
ATXS - ANVS
39%
Loosely correlated
-1.60%
AMLX - ANVS
38%
Loosely correlated
+1.33%
RXRX - ANVS
38%
Loosely correlated
-1.05%
IPSC - ANVS
38%
Loosely correlated
+3.15%
More